Larissa A Sambel

Dana Farber Cancer Institute Harvard Medical School

Claim

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 17 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Figure S7 from the CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

Kalindi Parmar,Bose S. Kochupurakkal,Jean-Bernard Lazaro,Zhigang C. Wang,Sangeetha Palakurthi,Paul T. Kirschmeier,Chunyu Yang,Larissa A. Sambel,Anniina Färkkilä,Elizaveta Reznichenko,Hunter D. Reavis,Connor E. Dunn,Lee Zou,Khanh T. Do,Panagiotis A. Konstantinopoulos,Ursula A. Matulonis,Joyce F. Liu,Alan D. D'Andrea,Geoffrey I. Shapiro

openalex（2023）

Cited0Views0Bibtex

Figure S6 from the CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

openalex（2023）

Cited0Views0Bibtex

Figure S1 from the CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

openalex（2023）

Cited0Views0Bibtex

Supplementary Table S1 from the CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

Kalindi Parmar,Bose S. Kochupurakkal,Jean-Bernard Lazaro,Zhigang C. Wang,Sangeetha Palakurthi,Paul T. Kirschmeier, Chunyu Yang,Larissa A. Sambel,Anniina Färkkilä,Elizaveta Reznichenko,Hunter D. Reavis,Connor E. Dunn,Lee Zou,Khanh T. Do,Panagiotis A. Konstantinopoulos,Ursula A. Matulonis,Joyce F. Liu,Alan D. D'Andrea,Geoffrey I. Shapiro

openalex（2023）

Cited0Views0Bibtex

Figure S2 from the CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure Legends from the CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

openalex（2023）

Cited0Views0Bibtex

Figure S3 from the CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

openalex（2023）

Cited0Views0Bibtex

Figure S4 from the CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

openalex（2023）

Cited0Views0Bibtex

TGFβ Pathway is Required for Viable Gestation of Fanconi Anemia Embryos

Alfredo Rodriguez,Michael Epperly,Jessica Filiatrault,Martha Velazquez,Chunyu Yang,Kelsey McQueen,Larissa A. Sambel,Huy Nguyen,Divya Ramalingam Iyer,Ulises Juarez,Cecilia Ayala-Zambrano,David B. Martignetti,Sara Frias,Renee Fisher,Kalindi Parmar,Joel S. Greenberger,Alan D. D'Andrea

PLOS GENETICS（2022）

Cited5Views0WOSBibtex

Inhibition of TGF1 and TGF3 Promotes Hematopoiesis in Fanconi Anemia

Alfredo Rodriguez, Chunyu Yang,Elissa Furutani,Benilde Garcia de Teresa,Martha Velazquez,Jessica Filiatrault,Larissa A. Sambel,Tin Phan,Patricia Flores-Guzman,Silvia Sanchez,Angelica Monsivais Orozco,Hector Mayani,Ozge V. Bolukbasi,Anniina Farkkila,Michael Epperly,Joel Greenberger,Akiko Shimamura,Sara Frias,Markus Grompe,Kalindi Parmar,Alan D. D'Andrea

EXPERIMENTAL HEMATOLOGY (2021): 70-U53

Cited0Views0Bibtex

Author Statistics

#Papers: 17

#Citation: 197

H-Index: 5

G-Index: 5

Sociability: 4

Diversity: 1

Activity: 1

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn